F-PDO® and F-PDX®: Advanced Tumor Organoid Models & Custom
Fujifilm Wako proudly offers two cutting-edge cancer research tools developed through the Fukushima Translational Research Project (Fukushima Project): F-PDO® (Fukushima Patient-Derived Tumor Organoids) and F-PDX® (Fukushima Patient-Derived Tumor Xenografts).
These patient-derived models provide valuable platforms for advanced oncology research and drug development. Leveraging our expertise and stringent quality management, Fujifilm Wako ensures reliable, safe, and high-quality supply of F-PDO® and F-PDX® models worldwide. Researchers can trust Fujifilm Wako to support their scientific endeavors with consistent and secure provision of these innovative cancer research tools.
- F-PDO®: Long-Term Patient-Derived Organoid Models & Assay Services
- We offer a characterized library of patient-derived organoid models established from Japanese cancer patients, alongside expert assay services to overcome the technical complexities of organoid research.
- F-PDX®: Japanese Patient-derived tumor xenograft
- Access a diverse inventory of PDX models mainly derived from Japanese patients for high-fidelity anti-cancer drug efficacy testing and biomarker discovery.
Fukushima Translational Research Project Outline
The Fukushima Translational Research Project (Fukushima Project) was launched as part of the post-Great East Japan Earthquake reconstruction measures supported by the Ministry of Economy, Trade, and Industry's (METI) FY2011 Third Supplementary Budget. It is an initiative that aims to both support the development of novel medical products, and promote the creation of new industry ventures by leveraging the cumulative achievements and technological expertise gained through numerous national METI projects associated with the biopharmaceutical industry.